- Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Anika Enters into Cooperation Agreement with Caligan Partners
- Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024
- Anika to Participate in the 23rd Annual Needham Virtual Healthcare Conference
- Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024
- Anika Highlights Its Recently Launched Integrity™ Implant System and RevoMotion™ Reverse Shoulder Arthroplasty System Along with Other Key Regenerative Products During the 2024 AAOS Annual Meeting
- Anika Announces First Surgeries Performed using the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Rotator Cuff Repairs, Commencing Limited Market Release
- Anika to Participate in Upcoming Investor Conferences
- Anika to Issue Third Quarter 2023 Financial Results on Thursday, November 2, 2023
- Anika Announces the Full Market Release of the RevoMotion™ Reverse Shoulder Arthroplasty System during the 2023 Orthopaedic Summit: Evolving Technologies (OSET) Annual Meeting
More ▼
Key statistics
On Tuesday, Anika Therapeutics Inc (ANIK:NSQ) closed at 25.93, -9.55% below its 52-week high of 28.67, set on May 08, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 25.99 |
---|---|
High | 26.23 |
Low | 25.61 |
Bid | 10.36 |
Offer | 28.00 |
Previous close | 25.99 |
Average volume | 68.24k |
---|---|
Shares outstanding | 14.83m |
Free float | 14.38m |
P/E (TTM) | -- |
Market cap | 380.50m USD |
EPS (TTM) | -5.24 USD |
Data delayed at least 15 minutes, as of Jun 18 2024 21:00 BST.
More ▼